- Home
- CBFV vs APLT Comparison
CBFV vs APLT Comparison
Compare CBFV & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- APLT
- Stock Information
- Founded
- CBFV 1901
- APLT 2016
- Country
- CBFV United States
- APLT United States
- Employees
- CBFV N/A
- APLT 28
- Industry
- CBFV Major Banks
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- APLT Health Care
- Exchange
- CBFV Nasdaq
- APLT Nasdaq
- Market Cap
- CBFV 174.9M
- APLT 38.1M
- IPO Year
- CBFV N/A
- APLT 2019
- Fundamental
- Price
- CBFV $34.49
- APLT $0.26
- Analyst Decision
- CBFV Buy
- APLT Buy
- Analyst Count
- CBFV 2
- APLT 5
- Target Price
- CBFV $36.00
- APLT $4.13
- AVG Volume (30 Days)
- CBFV 5.7K
- APLT 25.3M
- Earning Date
- CBFV 10-23-2025
- APLT 11-13-2025
- Dividend Yield
- CBFV 2.98%
- APLT N/A
- EPS Growth
- CBFV N/A
- APLT N/A
- EPS
- CBFV 0.51
- APLT N/A
- Revenue
- CBFV $39,329,000.00
- APLT $1,000,000.00
- Revenue This Year
- CBFV $10.71
- APLT N/A
- Revenue Next Year
- CBFV $12.52
- APLT $5,935.35
- P/E Ratio
- CBFV $68.57
- APLT N/A
- Revenue Growth
- CBFV N/A
- APLT N/A
- 52 Week Low
- CBFV $26.01
- APLT $0.22
- 52 Week High
- CBFV $35.37
- APLT $10.48
- Technical
- Relative Strength Index (RSI)
- CBFV 66.85
- APLT 28.24
- Support Level
- CBFV $32.70
- APLT $0.25
- Resistance Level
- CBFV $35.37
- APLT $0.40
- Average True Range (ATR)
- CBFV 0.75
- APLT 0.10
- MACD
- CBFV 0.20
- APLT -0.04
- Stochastic Oscillator
- CBFV 91.98
- APLT 5.13
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.